首页> 外文期刊>Journal of Obstetrics and Gynecology of India >HPV Vaccine: How Far have We Achieved?
【24h】

HPV Vaccine: How Far have We Achieved?

机译:HPV疫苗:我们取得了多大的成就?

获取原文
           

摘要

Globally, cervical cancer is the second most common cancer, and in India, it is the most common cancer in women. Human Papilloma virus (HPV) is the main cause of it. Although there are several methods for preventing cervical cancer, primary prevention by vaccination is the most effective option. HPV vaccine is safe and effective. It is expensive and is not a replacement for periodic cervical screening procedures. In developing countries, the cost effectiveness of vaccine and that of effective screening program with broader coverage is questionable. Today, HPV vaccine with regular cervical cancer screening program is the best possible tool to prevent cervical cancer.
机译:在全球范围内,子宫颈癌是第二大常见癌症,而在印度,它是女性中最常见的癌症。人乳头瘤病毒(HPV)是其主要原因。尽管有几种预防子宫颈癌的方法,但通过疫苗进行一级预防是最有效的选择。 HPV疫苗是安全有效的。它很昂贵,不能代替定期的宫颈筛查程序。在发展中国家,疫苗的成本效益以及覆盖面更广的有效筛查计划的成本效益值得怀疑。如今,定期进行子宫颈癌筛查计划的HPV疫苗是预防子宫颈癌的最佳工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号